CASP3 and B-cell chronic lymphocytic leukemia: In addition, we observed that treatment with scaffolded SRF231 in primary CLL cells or Ri-1 lymphoma cells did not induce caspase 3 cleavage as compared to the positive control venetoclax (Suppl.